US 10933130
Vaccines with interleukin-33 as an adjuvant
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 10933130 (Vaccines with interleukin-33 as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/55527, A61K2039/57